1. Hjjerpe, A., et al., Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology. Diagn Cytopathol, 2015. 43(7): p. 563-76.
  2. Hwang, H.C., et al., Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens. Am J Surg Pathol, 2016. 40(1): p. 120-6.
  3. Andrici, J., et al., Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology. Mod Pathol, 2015. 28(10): p. 1360-8.
  4. Nabeshima, K., et al., Use of p16 FISH for differential diagnosis of mesothelioma in smear preparations. Diagn Cytopathol, 2016. 44(9): p. 774-80.
  5. McGregor, S.M., et al., BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma. Hum Pathol, 201 46(11): p. 1670-8.
  6. 6. Savic, S., et al., Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology. Chest, 2010. 138(1): p. 137-44.